Sign in
Groups
Researchers
Funding
Results
Funding
Funder
:
GLENMARK PHARMACEUTICALS LIMITED
Scope
International (non-EU) (1)
Character
Private (1)
1 funding
- 607€
data available since 2021
2021
Experience In The Field of On Potential Indications of Molecules That Inhibit Nlrp3 And Potential Techniques To Use In The Design of Drugs That Inhibit Nlrp3.
euro
607.50
Contact
Legal notice
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de